4.6 Article

Accurate Molecular Classification of Kidney Cancer Subtypes Using MicroRNA Signature

期刊

EUROPEAN UROLOGY
卷 59, 期 5, 页码 721-730

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.eururo.2011.01.004

关键词

Biomarker; Cancer; Clear cell renal cell carcinoma; Chromophobe; Diagnosis; Kidney cancer; MicroRNA; miRNA; Oncocytoma; Papillary; Pathology; Profiling; Statistical classifier; Prognosis; RCC; Renal cancer; Subtypes; Tumour markers; Unclassified

资金

  1. Canadian Institute of Health Research (CIHR) [86490]
  2. Canadian Cancer Society (CCS) [20185]
  3. Ministry of Research and Innovation, Government of Ontario
  4. Kidney Foundation of Canada

向作者/读者索取更多资源

Background: Renal cell carcinoma (RCC) encompasses different histologic subtypes. Distinguishing between the subtypes is usually made by morphologic assessment, which is not always accurate. Objective: Our aim was to identify microRNA (miRNA) signatures that can distinguish the different RCC subtypes accurately. Design, setting, and participants: A total of 94 different subtype cases were analysed. miRNA microarray analysis was performed on fresh frozen tissues of three common RCC subtypes (clear cell, chromophobe, and papillary) and on oncocytoma. Results were validated on the original as well as on an independent set of tumours, using quantitative reverse transcription-polymerase chain reaction (qRT-PCR) analysis with miRNA-specific primers. Measurements: Microarray data were analysed by standard approaches. Relative expression for qRT-PCR was determined using the DDCT method, and expression values were normalised to small nucleolar RNA, C/D box 44 (SNORD44, formerly RNU44). Experiments were done in triplicate, and an average was calculated. Fold change was expressed as a log(2) value. The top-scoring pairs classifier identified operational decision rules for distinguishing between different RCC subtypes and was robust under cross-validation. Results and limitations: We developed a classification system that can distinguish the different RCC subtypes using unique miRNA signatures in a maximum of four steps. The system has a sensitivity of 97% in distinguishing normal from RCC, 100% for clear cell RCC (ccRCC) subtype, 97% for papillary RCC (pRCC) subtype, and 100% accuracy in distinguishing oncocytoma from chromophobe RCC (chRCC) subtype. This system was cross-validated and showed an accuracy of about 90%. The oncogenesis of ccRCC is more closely related to pRCC, whereas chRCC is comparable with oncocytoma. We also developed a binary classification system that can distinguish between two individual subtypes. Conclusions: MiRNA expression patterns can distinguish between RCC subtypes. (C) 2011 European Association of Urology. Published by Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据